Invention Grant
- Patent Title: Aptamer therapeutics useful in the treatment of complement-related disorders
-
Application No.: US16289374Application Date: 2019-02-28
-
Publication No.: US10947544B2Publication Date: 2021-03-16
- Inventor: Claude Benedict , David Epstein , Charles Wilson , Dilara McCauley , Jeffrey Kurz , Markus Kurz , Thomas Greene McCauley , James Rottman
- Applicant: ARCHEMIX LLC
- Applicant Address: US CA San Francisco
- Assignee: ARCHEMIX LLC
- Current Assignee: ARCHEMIX LLC
- Current Assignee Address: US CA San Francisco
- Agency: Haug Partners LLP
- Agent Jon E. Gordon
- Main IPC: C12N15/115
- IPC: C12N15/115 ; A61K47/60
Abstract:
The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
Public/Granted literature
- US20190185858A1 APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS Public/Granted day:2019-06-20
Information query
IPC分类:
